{"news_desk": "Business", "print_page": null, "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By ROBERT CYRAN", "person": [{"rank": 1, "role": "reported", "firstname": "Robert", "organization": "", "lastname": "CYRAN"}]}, "abstract": null, "type_of_material": "News", "word_count": "421", "lead_paragraph": "With so many questions about its financial information unanswered, Valeant\u2019s outlook is bleak.", "pub_date": "2016-03-16T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Valeant\u2019s Delay in Filing Audited Results Adds to Discord", "content_kicker": "Breakingviews", "kicker": "Breakingviews"}, "snippet": "With so many questions about its financial information unanswered, Valeant\u2019s outlook is bleak.", "multimedia": [], "web_url": "http://www.nytimes.com/2016/03/16/business/dealbook/valeants-delay-in-filing-audited-results-adds-to-discord.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Company Reports", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Valeant Pharmaceuticals International Inc", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Pearson, John Michael (1959- )", "name": "persons"}], "blog": [], "_id": "56e852e638f0d85c820e631f", "source": "The New York Times"}